H.T. Mouridsen

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

C. Focan, S. M. Steinberg, M Blichert-Toft et al. · PubMed · 1998 · 2.2K citations

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women

I. Craig Henderson, H.T. Mouridsen, O Abe et al. · 1988 · 628 citations

Breast Oncology, Early Breast Cancer, Medicine +8

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.

J Grøndahl-Hansen, I. J. Christensen, Christian Rosenquist et al. · PubMed · 1993 · 390 citations

Urology, Oncology, Urokinase Pathway +14

Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group.

M Blichert-Toft, C. Sainte Rose, J. A. Andersen et al. · PubMed · 1992 · 375 citations

Surgical Oncology, Breast Oncology, Cancer Management +16

Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study.

Bent Bruun Kristensen, Bent Ejlertsen, Peter Dalgaard et al. · Journal of Clinical Oncology · 1994 · 201 citations